The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $60.90

Today's change-0.56 -0.91%
Updated September 25 11:50 AM EDT. Delayed by at least 15 minutes.
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $60.90

Today's change-0.56 -0.91%
Updated September 25 11:50 AM EDT. Delayed by at least 15 minutes.

NU Skin Enterprises Inc crosses below 50-day moving average

NU Skin Enterprises Inc is lower today, dropping (U.S.)$0.56 or 0.91% to (U.S.)$60.90 and crossing below its 50-day moving average. Shares have lost 1.04% over the last five days, but have gained 27.46% over the last year to date. This security has underperformed the S&P 500 by 18.66% during the last year.

Key company metrics

  • Open(U.S.) $61.39
  • Previous close(U.S.) $61.46
  • High(U.S.) $61.77
  • Low(U.S.) $60.86
  • Bid / Ask(U.S.) $60.89 / (U.S.) $60.98
  • YTD % change+27.46%
  • Volume71,408
  • Average volume (10-day)413,715
  • Average volume (1-month)773,175
  • Average volume (3-month)603,439
  • 52-week range(U.S.) $46.35 to (U.S.) $66.04
  • Beta1.43
  • Trailing P/E20.59×
  • P/E 1 year forward19.02×
  • Forward PEG2.19×
  • Indicated annual dividend(U.S.) $1.44
  • Dividend yield2.36%
  • Trailing EPS(U.S.) $2.96
Updated September 25 11:50 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.53%

Based on its net profit margin of 7.53%, NU Skin Enterprises Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.11%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue550499531604
Total other revenue--------
Total revenue550499531604
Gross profit429388423478
Total cost of revenue122111109126
Total operating expense485453471522
Selling / general / administrative364342362396
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income65466182
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax62426277
Income after tax42273857
Income tax, total20142420
Net income42273857
Total adjustments to net income--------
Net income before extra. items42273857
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items42273857
Inc. avail. to common incl. extra. items42273857
Diluted net income42273857
Dilution adjustment--------
Diluted weighted average shares55545558
Diluted EPS excluding extraordinary itemsvalue per share0.770.510.700.98
Dividends per sharevalue per share0.360.360.360.36
Diluted normalized EPSvalue per share0.770.510.700.98